Project Grant HT94252310789

The federal Project Grant award of $1,949,901.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Salisbury Foundation For Research And Education, doing business as Hefner Ba Medical Center, on the relationship between blast exposure and cellular senescence in veterans. The award period runs from September 1, 2025 to August 31, 2029. The research aims to investigate the impact of blast exposure on hippocampal volume and...

This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...

This $4,626,921 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant was awarded on August 1, 2025 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization in Bethesda, Maryland. The research aims to elucidate the role of the...

This federal Project Grant award, with a funding amount of $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on innovative research addressing critical health challenges. The specific project, titled "IN VIVO NEUROEPIGENETICS IN COMBAT VETERANS WITH...

The federal Project Grant award of $161,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Duke University to investigate breast cancer brain metastases. The research aims to integrate immunogenomic and phenotypic vulnerabilities to improve outcomes for this challenging condition. The award period runs from April 1, 2025 to March 31, 2026. This grant is part of the Defense Health Agency's strategic...

The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...

The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...

The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...

This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $564,705.00 to Duke University to conduct research on identifying "oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma." The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in cancer...

This Project Grant award, valued at $2,411,921.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports cognitive rehabilitation research aimed at treating anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The project will be conducted by Duke University's Office of Research Administration Division, a leading provider of advanced medical research to federal agencies....